von Eyben Finn Edler, Madsen Ebbe Lindegaard, Fritsche Herbert, Suciu Gabriel, Liu Frank, Amato Robert
Center of Tobacco Research, Odense, Department of Oncology, Soenderborg Hospital, Denmark.
APMIS. 2003 Jan;111(1):100-5; discussion 105. doi: 10.1034/j.1600-0463.2003.1110114_1.x.
In univariate analyses of patients with metastatic testicular germ cell tumours (TGCT), both the International Germ Cell Consensus Classification (IGCCC) and serum lactate dehydrogenase (S-LD) isoenzyme 1 catalytic concentration (S-LD-1) significantly predicted survival. In complementary analyses of 81 patients with metastatic TGCT, S-LD and S-LD-1 classified the prognosis differently for 23 patients. In multivariate Cox hazard analyses of risk factors, only IGCCC and S-LD-1 predicted the prognosis (p=0.036, and p=0.0007, respectively). A new prognostic model based on prognostic information from main histology, IGCCC, and S-LD-1 changed the prognostic prediction by IGCCC for 19 patients (24%). Judged by to the area under the curve for receiver operation characteristics curves, the new model predicted five-years survival for the patients better than IGCCC and a modified version of the third edition of the TNM classification (p=0.025, and p=0.01, respectively). However, new studies should validate the new model before it is recommended as a general classification system of patients with metastatic TGCT.
在转移性睾丸生殖细胞肿瘤(TGCT)患者的单因素分析中,国际生殖细胞共识分类(IGCCC)和血清乳酸脱氢酶(S-LD)同工酶1催化浓度(S-LD-1)均显著预测了生存率。在对81例转移性TGCT患者的补充分析中,S-LD和S-LD-1对23例患者的预后分类不同。在风险因素的多因素Cox风险分析中,只有IGCCC和S-LD-1预测了预后(分别为p = 0.036和p = 0.0007)。基于主要组织学、IGCCC和S-LD-1的预后信息建立的新预后模型改变了IGCCC对19例患者(24%)的预后预测。根据受试者操作特征曲线下面积判断,新模型对患者五年生存率的预测优于IGCCC和TNM分类第三版的修订版(分别为p = 0.025和p = 0.01)。然而,在新模型被推荐作为转移性TGCT患者的通用分类系统之前,新的研究应验证该模型。